- 1000 Genomes Project
- 23andMe
- 27HC
- 3D
- 454 Life Sciences
- 7TM Pharma
- a-synuclein
- Abilify
- Abiraterone
- Ablynx
- ABT-737
- academic partnership
- academic research
- Acceleron
- acetaminophen
- acetylcholine
- acne
- Acute myeloid leukemia
- Adams-Oliver Syndrome
- addiction
- Adenovirus
- ADHD
- adult stem cells
- advanced cell technology
- Afraxis
- Africa
- African-Americans
- aging
- Aicar
- AIDS
- AIDS research
- AIDS vaccine
- Alan Lewis
- Alan Trounson
- Albany Medical Center Prize
- alcohol
- Aled Edwards
- alemtuzumab
- Allan Jones
- allergies
- Alnylam
- alpha-7
- ALS
- Alzheimer's
- Alzheimer's Parkinson's viruses
- Alzheimer's test
- Amanita phalloides
- Ambien
- Amgen
- amino acid
- amniotic stem cells
- Amylin Pharmaceuticals
- amyloid plaque
- amyloidosis
- amyotrophic lateral sclerosis
- anaphylactic shock
- Andreas Barner
- Angelica sinesis
- angina
- Anil Potti
- Animal
- animal models
- Animal Rights
- animal testing
- Ann Arbor
- Anthony S. Fauci
- anthrax
- anti-aging
- anti-inflammatory
- antibiotic-resistant bacteria
- antibiotics
- antibodies
- Antibody
- antidepressant
- antioxidants
- antipsychotic
- antiviral drugs
- Anton
- anxiety
- Apogee Biotechnology
- Applied Biosystems
- Ardian
- arsenic
- arthritis
- artifical ovary
- artificial antibodies
- artificial artery
- artificial blood
- artificial DNA
- artificial heart
- artificial liver
- artificial lung
- artificial organs
- artificial pancreas
- artificial proteins
- ASCO
- Asperger's
- aspirin
- Associated Press
- asthma
- AstraZeneca
- astrocytes
- atherosclerosis
- Athersys
- Athleticode
- ATOH1
- Atoh1 gene
- Aura Biosciences
- Australia
- autism
- autistic spectrum disorder
- autoimmune diseases
- Avastin
- Avaxia Biologics
- AVI BioPharma
- Avian flu
- AvidBiotics
- Axons
- backpacks
- bacteria
- baking soda
- baldness
- BARDA
- Barrett's dysplasia
- Bayer Healthcare
- Baylor College of Medicine
- Bert Sakmann
- beta amyloid
- Bill & Melinda Gates Foundation
- bioanalytics
- biochemistry
- Biochemists
- Biocon
- biodefense
- bioengineering
- biofilms
- Biogen Idec
- Bioheart
- bioinformatics
- biologic
- biological engineering
- biomarkers
- biomedical research
- BioPharmaIT
- Bioprospecting
- biopsy
- biosensors
- biosimilars
- biotech bankruptcy
- biotech investment
- biotech jobs
- bioterror
- bioterrorism
- BioTime
- bipolar disorder
- bird flu
- birth control
- bladder cancer
- Blaze Bioscience
- blindness
- blood cells
- Blood Clots
- Blood vessel
- blood vessels
- Blood-brain barrier
- Bloomberg News
- bluebird bio
- Boehringer Ingelheim
- bone loss
- bone marrow
- bone marrow stem cells
- bone regeneration
- bone repair
- bone tissue
- Boris Pasche
- Boston Globe
- Boston University
- brain
- brain cancer
- brain cells
- brain tumor
- BrainCells
- breast cancer
- breast cancer vaccine
- breast reconstruction
- brevetoxin
- Bristol-Myers Squibb
- Broad Institute
- brown fat
- Brown University
- Bruce Ivins
- Brucella
- Buck Institute for Age Research
- Burnham Institute
- cabergoline
- caffiene
- calif
- California
- California Institute for Regenerative Medicine
- Caltech
- Cambridge
- Canada
- Canadian Cancer Society
- Cancer
- cancer cells subtypes
- cancer cure
- Cancer Drugs
- cancer pain
- Cancer Research
- Cancer Research UK
- Cancer Treatment
- cancer vaccine
- Capricor
- cardiac damage
- cardiac repair
- cardiac stem cells
- Cardio3 Biosciences
- Carl June
- Carmat
- Carol Zhu
- Case Western Reserve University
- cathelicidin
- Catherine Verfaillie
- CD47
- CDI
- celiac disease
- Cell Biology
- cell death
- cell division
- Cell fusion
- cell phones
- Cellceutix
- Cellular Dynamics
- Cellzome
- Cenre for Addiction and Mental Health
- Center for Human Genetic Research
- Center for Stem Cell and Regenerative Medicine
- Centers for Disease Control
- central nervous system
- Centre for Medical Research and Innovation
- cerebral palsy
- Charcot-Marie-Tooth disease
- Charles Natanson
- Charles River
- chemotherapy
- children
- Children's Hospital & Research Center Oakland
- Children's Hospital Los Angeles
- chimera
- Chimerix
- chimpanzees
- China
- Chinese medicinal herb
- chocolate
- cholesterol
- Chonnam National University
- Christoph Westphal
- Christus Stehlin Foundation
- chronic diarrhea
- chronic fatigue
- chronic fatigue syndrome
- chronic myelogenous leukemia
- Chronic Pain
- Cidofovir
- Cincinnati Children's Hospital Medical Center
- cirrhosis
- Cisplatin
- City of Hope National Medical Center
- Cleveland
- Cleveland Clinic
- Clifford Reid
- clinical researchers
- Clinical Trial
- clinical trials
- cloning
- Clostridium difficile
- CLR01
- cocaine
- cognitive function
- COL5A1
- colchicine
- collaboration
- colon cancer
- Colorectal Cancer
- Columbia University
- Columbia University Medical Center
- compensation
- Complete Genomics
- Compugen
- Concordia University
- conflict of interests
- congestive heart failure
- Congress
- Connecticut
- Convergence
- COPD
- cord blood
- Cord Blood Registry
- Corey Goodman
- Cornell
- cortisol
- Cougar Biotechnology
- covalent bonds
- Covance
- CPEB4
- Craig Venter
- critics
- CRO
- CRT0066101
- Crucell
- CS-8958
- curcumin
- CVRx
- Cybrids
- cyclodextrin
- cystic fibrosis
- Cytori
- D3 receptor
- Dalton Transactions
- Dana Farber Cancer Institute
- Dana-Farber Cancer Institute
- Darapladib
- DARPA
- DARPP-32
- David Baker
- David E. Shaw
- David Feldheim
- David Jensen
- David Sinclair
- DaVinci Biosciences
- DCC gene
- deals
- death
- death cap mushroom
- Decode Genetics
- deltaFosB
- dementia
- dendritic cells
- dengue fever
- Denosumab
- Department of Defense
- depression
- dermatology
- designer babies
- designer drugs
- Detroit Medical Center
- Diabetes
- diagnosis
- Dimebon
- disclosure
- disease weather map
- Dkk1 protein
- DNA
- DNA damage
- DNA Methylation
- DNA sequencing
- dopamine
- dosinex
- Down syndrome
- Dr. Joshua Hare
- Dr. Robert Gallo
- Dr. Zheng Cui
- Draper Laboratory
- drug abuse
- drug class
- Drug combinations
- drug combos
- drug data
- drug delivery
- drug delivery systems
- drug development
- drug develpment
- drug discovery
- drug safety
- Drug simulation technology
- drug targets
- Drugs for Neglected Diseases Initiative
- Duke University
- E-therapeutics
- E. coli
- E.coli
- early-stage research
- Ebola
- economic development
- education
- eggs
- Eicosapentaenoic Acid
- Election 2008
- Eli Lilly
- Elias Zerhouni
- Elizabeth Blackburn
- Elizabeth Thomas
- embronic stem cells
- embryo
- Embryo Project
- embryonic stem cell research
- embryonic stem cells
- embryos
- Emory University
- Emory University School of Medicine
- Emotional Disorders
- emphysema
- energy drink
- EnGeneIC
- EnGenelC Delivery Vehicle
- Enobia Pharma
- Entelos
- Entrepreneurs
- Enzymes
- epigenetics
- Erasmus Medical Center
- Erbitux
- Eric Lander
- Eric Topol
- esophageal cancer
- Esperion Therapeutics
- Europe
- European Commission
- exercise
- exome sequencing
- EyeCyte
- failure
- FAK proteins
- Fanapt
- FasterCures
- Fasudil
- fat bubbles
- fat cells
- Fate Therapeutics
- Fatostatin
- FDA
- FDA approval
- FDA news
- FDA regulation
- FDA update
- Feinberg School of Medicine
- fertility
- Fever
- fiber optics
- fibroblasts
- fingolimod
- Fiorenzo Omenetto
- fish oil
- flavonoid
- Florida
- flu
- Fludase
- fluorene compounds
- fluoxetine
- Foldit
- FoldRx
- food-borne bacterial infection
- Foot And Mouth Disease
- Fosamax
- Fragile X
- France
- Francis Collins
- fraud
- frog skin secretions
- Fruits And Vegetables
- fumagillin
- funding
- fusion transcripts
- gamers
- gaming
- gastrin
- GE Healthcare
- gel
- Gelesis
- gene biomarkers
- gene mutation
- gene regulation
- gene sequencing
- gene therapy
- Genentech
- genetic analysis
- genetic diversity
- genetic engineering
- genetic mutations
- genetic sequencing
- genetic testing
- genetic variation
- genetically engineered animals
- genetics
- Genetix
- genome
- genome sequencing
- Genomes Unzipped
- Genomics
- Genzyme
- George Church
- George Daly
- George Honig
- Georgetown University Medical Center
- Georgia Institute of Technology
- Geron
- ghrelin
- Gilead
- Gladstone Institutes
- Glasgow University
- glaucoma
- GlaxoSmithKline
- glioblastoma
- gliomas
- glucagon
- glucose
- Glycofi
- glyoxylate shunt
- GMP
- GnuBio
- gonorrhea
- Good Cholesterol
- GPUs
- Graft-versus-Host Disease
- grant
- grape seed extract
- Grape Skin
- grass-roots organizations
- guardian
- GW1516
- H5N1
- H7N2
- hair
- hallucinogens
- Hani Atamna
- Hansjörg Wyss
- Hanyang University
- Haptogen
- Harold Varmus
- Harrington Project for Discovery & Development
- Harvard Medical School
- Harvard University
- HDAC
- HDL-C
- HE3235
- head and neck cancer
- hearing loss
- heart
- heart arrhythmia
- heart attack
- heart attack damage
- heart attacks
- heart disease
- heart muscle
- heart tissue
- heart valves
- heat-based cancer therapy
- Helicos BioSciences
- hemophilia b
- Hendra
- Hendra Virus
- Hepatitis C
- Hepregen
- High blood pressure
- HIPAA
- HIV
- Hollis-Eden
- Hongjie Dai
- Hormone Replacement Therapy
- hormones
- Hospital del Mar
- Howard Hughes Medical Institute
- HP
- human blood stem cells
- Human Embryonic Stem Cell
- Human Genome Project
- human stem cells
- Huntington's Disease
- Huntsman Cancer Institute
- Hwang Woo Suk
- Hybrid embryos
- Hybrids
- hypertension
- hypophosphatasia
- Ian Frazer
- Ian Mills
- IBM
- ICT2588
- Illumina
- imaging
- immune system
- Immuneering
- immunity
- immunoglobulin
- Immunology
- Imperial College London
- in vitro
- India
- infants
- infection
- infectious disease
- inflammation
- influenza
- Inkjet technology
- Inovio Biomedical
- insomnia
- Institute for Research Barcelona
- insulin
- Interdisciplinary Stem Cell Institute
- International Partnership for Microbicides
- intestinal bacteria
- investigators
- Ion Torrent
- iPierian
- iPill
- iPS cells
- irisin
- irritable bowel syndrome
- iSense
- Italian Institute of Technology
- itching
- itraconazole
- IVF
- iZumi Bio
- Jackson Laboratory
- James Kovach
- James Thomson
- Japan
- Jay Tenenbaum
- Joan Steitz
- John Holdren
- John Novembre
- John Quackenbush
- Johns Hopkins
- Johns Hopkins School of Medicine
- Johns Hopkins University
- Johnson & Johnson
- Jolee Mohr
- Joseph DeSimone
- Joslin Diabetes Center
- Journal of Clinical Investigation
- Jubilant
- Judah Folkman
- Jung Han Yoon Park
- Juvenile Diabetes Research Foundation
- K-RAS gene
- Kari Stefansson
- Karl Saxe
- kartogenin
- Kathleen Sebelius
- Kenneth Shea
- Kevetrin
- Kevin Shakesheff
- kidney cancer
- kidney disease
- kidney tranplant
- kidneys
- Knome
- Korea
- korean researchers
- Kymab
- lab mice
- lab safety
- lactalbumin
- Lasker Prize
- Laurence Goldstein
- learning disabilities
- Lenaldekar
- leptin
- leukemia
- Libradyn
- lisinopril
- lithocholic acid
- liver cancer
- liver damage
- Liver enzymes
- Living Cell Technologies
- lodamin
- Longevity
- Lorry Lokey
- losartan
- Lou Gehrig's disease
- low-intensity electromagnetic fields
- LOXL1
- Luc Montagnier
- LucCell
- lung cancer
- lung disease
- lung progenitors
- lymphoma
- Lymphoma Treatment
- Lyon Cancer Research Centre
- M&A
- macular degeneration
- Maine
- Malaria
- male birth control
- male contraceptive
- mannitol
- manufacturing
- Marburg
- Marc Cluzel
- Margaret Hamburg
- marijuana
- Marius Wernig
- market trends
- Marshall Institute for Interdisciplinary Research
- Martin Mackay
- Massachusetts
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- maternal
- Max Planck Society
- Mayo Clinic
- McGill University
- MD Anderson Cancer Center
- MDMA
- measles
- Medco
- medical college of georgia
- Medical College Of Wisconsin
- Medical Research Council
- Medivation
- medulloblastoma
- melanoma
- melatonin
- Memories
- meningitis
- Merck
- Merck KGaA
- Merial Animal Health
- merkel cell carcinoma
- messenger rna
- metabolic profiling
- metabolism
- Metamark Genetics
- metastasis
- metformin
- methamphetamine
- Methodist Hospital
- MGH
- Mice
- Michael Clarke
- Michael Krawczak
- Michael Parker
- Michigan
- microbe
- microchip
- microdosing
- microfluidics
- microparticles
- microRNA
- Microrobot
- microrobots
- microscopy
- migraine
- Millipore
- Minnesota
- minocycline
- miRNA
- MIT
- Mitofusin 2
- molecular research
- molecules
- monkeys
- monoclonal antibodies
- morphine
- mouse connective tissue
- mouse fetuses
- MRSA
- MT2
- Muhammad Zaman
- Multaq
- multiple myeloma
- multiple sclerosis
- muscular dystrophy
- Myc oncogene
- myelin
- Myriad Genetics
- nanobodies
- nanoparticle
- nanoparticles
- nanopopcorn
- Nanoscale
- nanosensors
- nanotechnology
- Nanotechnology regulation
- nanotechnology safety
- nanotube
- nantubes
- narcolepsy
- NASA
- National Cancer Institute
- National Center for Advancing Translational Sciences
- National Children's Study
- National Health Service
- National Institutes of Health
- National Science Foundation
- natural treatments
- Nature
- Nature Immunology
- Nature Medicine
- NDM-1
- NEJM
- Nektar Therapeutics
- NeoStem
- nerve cells
- nerve damage
- nerves
- Neu5Gc
- neuerodegenerative disorders
- Neuralstem
- Neuro-Oncology
- neuroblastoma
- neurodegenerative disease
- neuroendocrine
- neurological
- Neuron
- neurons
- neuroreceptors
- neuroscience
- neurotransmitter
- neurotrophic factor
- never-smokers
- New England Journal of Medicine
- New Jersey
- New Orleans
- New York
- NexBio
- Nicholas Wade
- nicotine
- NIH
- Nipah
- Nipah Virus
- nitroglycerin
- Northwestern University
- Norway
- NOSH
- NOTCH inhibitors
- NOTCH-1
- Novartis
- Novartis Institutes for BioMedical Research
- Novocell
- NOX2
- NP-C disease
- NPC
- nucleozin
- NYU Langone Medical Center
- Obama Administration
- obesity
- obesity drugs
- obesity receptor
- Obsessive-compulsive disorder
- OCD
- Ohio State University
- omaga-3
- Omega Fatty Acids
- oncology
- OncoMed
- Oncotarget
- OneWorld Health
- open-source
- OpGen
- Optogenetics
- oral cancer
- Oregon Health & Science University Knight Cancer Institute
- organ growth
- organ rejection
- organ transplants
- organic
- Organovo
- Osiris
- osteoarthritis
- osteoporosis
- outbreak
- outsourcing
- ovarian cancer
- Ovarian Cancer Patients
- ovarian stem cells
- Oxford Nanopore Technologies
- Oxford University
- p53
- Pacific Biosciences
- Pain therapy
- pancreas
- pancreatic cancer
- pandemic
- paralysis
- Parkinson Disease
- Parkinson's disease
- PARP Inhibitor
- partnering initiative
- patents
- patient groups
- Paul Nurse
- Paul Stoffels
- PD173074
- pediatric
- Penn State
- peptides
- personalized medicine
- personalized treatments
- PETA
- Peter McKinnon
- pets
- Pew Charitable Trusts
- Pfizer
- pharma gifts
- Phase I
- philanthropy
- Philips Research
- Phox-I
- Pieris
- PiggyBac
- PIKAMAB
- pipeline
- pituitary gland
- PKCepsilon
- PKMzeta
- PKR molecule
- placebo effect
- placenta
- plaque
- plastic antibodies
- platelets
- Plauge
- Plexxikon
- PLoS One
- pluripotent stem cells
- Pluristem Therapeutics
- PLX4032
- PNAS
- pneumonia
- Post Traumatic Stress Disorder
- Post Traumatic Stress Syndrome
- postdoc
- PRDM16
- preclinical
- Preclinical Developments
- preclinical research
- Premature aging syndrome
- President Barack Obama
- preterm birth
- preventative vaccine
- Prexige
- privacy
- PRO2000
- probiotic
- Proceedings of the National Academy of Sciences
- Proceedins of the National Academy of Sciences
- progenitor cells
- progeria
- Prometheus Laboratories
- propolis
- prostate cancer
- protein
- protein chemistry
- protein kinase G
- proteins
- Proteostasis Therapeutics
- Prozac
- psychiatric drugs
- psychiatrists
- pulmonary fibrosis
- Puma
- Punam Malik
- pyy
- Queen's University
- Quercetin
- R&D
- R&D spending
- RAD51D
- radiation
- radiation exposure
- RAGE
- raloxifene
- Ralph M. Steinman
- rare diseases
- rats
- Raymond DuBois
- Red Tide
- Red Wine
- regenerative medicine
- REGiMMUNE
- regulation
- Regulators
- Regulus Therapeutics
- relcovaptan
- Rene Hen
- ReNeuron
- Rennselaer Polytechnic Institute
- Rensselaer Polytechnic Institute
- reovirus
- reprogram
- research
- research groups
- resistant
- restructuring
- resveratrol
- Reuters
- reVax
- RHBDF2
- Rheumatoid Arthritis
- RhoGDI2
- Richard Pazdur
- Rick Perry
- Ritalin
- RNA
- RNAi
- Robert Epstein
- Robert Gallo
- Robert Klein
- Robert Langer
- Robert Lanza
- Roche
- Rockefeller University
- Rocky Tuan
- Ronald DePinho
- Rosacea
- Rosetta@home
- Rudolf Jaenisch
- Rutgers
- RXi Pharmaceuticals
- salary
- Salk Institute
- Salk Institute for Biological Studies
- salsalate
- SAMHD1
- San Diego
- San Francisco
- Sangamo BioSciences
- Sanofi
- Sanofi-Aventis
- Santaris Pharma
- Sarcopenia
- Satori Pharmaceuticals
- schizophrenia
- SCID-X1
- scientific research
- Scotland
- Scripps Research Institute
- Seaside Therapeutics
- secondary complication
- septic shock
- Serologicals
- Serotonin
- Shinya Yamanaka
- sickle cell anemia
- side effects
- silicon
- silver
- Simon Frazer University
- Singapore
- Sinovac
- Sir Chris Evans
- Sir Leszek Borysiewicz
- Sir Martin Evans
- Sirt1
- Sirtis Pharmaceuticals
- Sirtris
- Sirtuin
- SIV
- skin cancer
- skin cells
- sleep deprivation
- sleepwalking
- Slentrol
- SMAD signaling
- small biotechs
- smallpox
- SMT 19969
- social networking
- sorafenib
- Spencer Pharmaceutical
- SphK1
- spin-off
- squamous cell cancer
- squamous cell carcinoma
- SRT501
- St. Jude Children's
- Stanford University
- Stanford University School of Medicine
- start-up
- state funding
- Stefan Kappe
- stem cell
- stem cell production
- stem cell research
- stem cell therapies
- stem cell trial
- Stem Cells
- Stemgent
- Stephen Wong
- Steven Shoelson
- STF-62247
- stomach cancer
- Stomach ulcers
- stress
- stroke
- Structural Genomics Consortium
- Substance P
- sugar
- sugar molecules
- Summit
- Sun1
- Sunburn
- supercomputer
- Supramap
- survival rates
- sutures
- swine flu
- Switzerland
- Sylvain Martel
- SynDevRx
- syntheic
- synthetic biology
- synthetic blood
- synthetic DNA
- synthetic lethality
- T cells
- T-cell
- T-cell acute lymphoblastic leukemia
- TAK-1 inhibitor
- TAK-491
- Takeda Pharmaceutical
- tamoxifen
- tarantula venom
- Tarceva
- Targacept
- Targeted Genetics
- tasimelteon
- tau
- tau proteins
- taxanes
- telomerase
- telomerase enzymes
- Terry McGuire
- testosterone
- Texas A&M
- tgAAC94
- TGF-beta
- the British Journal of Cancer
- The City College of New York
- the jackson laboratory
- The New York Times
- The Vatican
- Third Rock Ventures
- Thomas Jefferson University
- thrombosis
- tipifarnib
- tissue repair
- TNF alpha
- tobacco
- ToleroVax
- Tolerx
- TopBP1
- topiramate
- Transgenics
- Translational Genomics Research Institute
- translational research
- transparency
- transplants
- transposons
- trauma
- traumatic brain injury
- Treg effect
- triple-negative breast cancer
- tuberculosis
- Tufts University
- tumor markers
- tumor resistance
- tumor suppression
- tumors
- turmeric
- tylosis
- type 1 diabetes
- type 2 diabetes
- type I diabetes
- type II diabetes
- U.K.
- U.S. Supreme Court
- U.T. San Antonio
- UC Davis
- UC San Diego School of Medicine
- UC San Francisco
- UCLA
- UCSF
- umbilical cord blood
- United Kingdom
- United Therapeutics
- Unither Virology
- universities
- University College London
- University Of Alabama
- University of Alberta
- university of arizona
- University of Bonn
- University of California
- University of California Davis
- University of California Los Angeles
- University of California San Diego
- University of Chicago
- University Of Colorado Cancer Center
- University of Edinburgh
- University of Illinois
- University of Iowa
- University of Kansas
- University of London
- University of Melborne
- University of Miami
- University of Michigan
- University of North Carolina at Chapel Hill
- University of Pennsylvania School of Medicine
- university of pittsburgh
- University of Pittsburgh School of Medicine
- University of Queensland
- University of Rochester Medical Center
- University of Sheffield
- University of South Carolina
- University of Southern California
- University of Texas
- University Of Texas Childrens Cancer Hospital
- university of texas health science center at houston
- University of Warwick
- University of Wisconsin
- university research
- Univesity of Leeds
- USC
- USDA Western Regional Research Center
- UT San Antonio
- vaccine
- Valium
- valve
- Van Andel Research Institute
- Vanda Pharmaceuticals
- Vaptans
- vasopressin
- Vectibix
- Venrix
- Venture Capital
- venture philanthropy
- Verastem
- Vertex Pharmaceuticals
- ViaCyte
- virus
- vision loss
- Vitamin C
- vitamin D
- volunteers
- Wake Forest University
- wake forest university school of medicine
- Wayne State University
- Weizmann Institute of Science
- Wellcome Trust
- whistleblower
- white blood cells
- WHO
- William Brody
- Wistar Institute
- World Stem Cell Summit
- Wound healing
- Wyeth
- X chromosome
- X Prize
- Xceleron
- XMRV
- XNA
- Yale
- Yale University
- zebrafish
- Zev Rosenwaks
- Ziopharm
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- BioImmersion CourseMay 23-25 — Chicago, IL
- Don't miss an Exclusive Executive Breakfast at BIO 2012!June 19, 2012 — Boston, MA
Latest Commentary